Ensysce Biosciences Inc. – Filings and Transcripts

NASDAQ: ENSC
Share price (8/19/26): $0.39
Market cap (8/19/26): $7.549 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Shelf registration

Registration of securities for employees

Shelf registration

Shelf registration

Prospectus supplement for primary offering

Ownership Filter

Morrison James William

Adage Capital Management, L.P.

Perceptive Advisors LLC

News Filter

Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Announces Acquisition of Cy Biopharma and Up to $77 Million Private Financing

Announces Acquisition of Cy Biopharma and Up to $77 Million Private Financing

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness